Transactions
Veristat Group recapitalized by WindRose Health Investors
Apr. 2021
Client: Veristat Group is a scientifically minded global clinical research organization that empowers biotech and pharmaceutical sponsors to solve unique and complex challenges associated with accelerating innovative therapies from clinical development to regulatory approval and post-approval
Role: Edgemont Partners acted as exclusive financial advisor to Veristat Group in its recapitalization by WindRose Health Investors
Location: Southborough, MA
Sector: Pharmaceutical Services
Lead Banker: David Blume
recapitalized by
